Substance / Medication

Oxytetracycline

Overview

Active Ingredient
oxytetracycline
RxNorm CUI
7821

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

113 trials linked to this intervention

113
Total Trials
8
Recruiting
69
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Meta-analysis of pharmacokinetic data of veterinary drugs using the Food Animal Residue Avoidance Databank: oxytetracycline and procaine penicillin G.
Craigmill A L, Miller G R, Gehring R et al. · J Vet Pharmacol Ther · 2004
PMID: 15500573Meta-Analysis
Effect of different oral oxytetracycline treatment regimes on selection of antimicrobial resistant coliforms in nursery pigs.
Herrero-Fresno Ana, Zachariasen Camilla, Nørholm Nanna et al. · Vet Microbiol · 2017
PMID: 28888623RCT
Targeted antibiotic treatment of lame sheep with footrot using either oxytetracycline or gamithromycin.
Strobel H, Lauseker M, Forbes A B · Vet Rec · 2014
PMID: 24362004RCT
Prevalence and effect of oxytetracycline on congenital fetlock knuckling in neonatal dairy calves.
Fazili Mujeeb R, Bhattacharyya Hiranya K, Mir Manzoor u R et al. · Onderstepoort J Vet Res · 2014
PMID: 25686378RCT
Influence of oxytetracycline on carprofen pharmacodynamics and pharmacokinetics in calves.
Brentnall C, Cheng Z, McKellar Q A et al. · J Vet Pharmacol Ther · 2013
PMID: 22913421RCT
Topical 1% oxytetracycline hydrochloride versus placebo in oral mucosa biopsy.
López-Jornet Pia, Camacho-Alonso Fabio, Martinez-Canovas Ascensión et al. · Dermatol Surg · 2012
PMID: 22455385RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Oxytetracycline (substance)
SNOMED CT
372675006
UMLS CUI
C0030092
RxNorm CUI
7821

Clinical Data

This intervention maps to 14 entities in the Healos knowledge graph.

14
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
113
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.